Multi-Shape Polygon Visualization for Insulin Dose Variability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current systems for managing insulin treatment in diabetes patients lack effective visualization tools to communicate the distribution and variability of insulin injections, making it difficult to understand the appropriateness of treatment regimens for glucose control.
Innovation Solution
A device and method that utilize processors and memory to obtain and structure injection data, creating multi-shape data structures to represent the average and variability of insulin injections over time, allowing for visualization and communication of dose history to patients or healthcare providers.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Loss of information
If traditional insulin delivery systems are used with simple dose recording, then device complexity is reduced, but the ability to visualize and communicate dose distribution and variability is insufficient
Solution Approach 1:
The patent segments the dose history data into multiple time windows (e.g., morning, afternoon, evening periods) and divides the day into standard time periods (7 AM-1 PM, 1 PM-7 PM, 7 PM-1 AM). This segmentation allows complex dose distribution patterns to be broken down into manageable, visually representable segments, each with its own statistical characteristics (average dose, coefficient of variation), making the overall complex information more digestible while preserving detailed information about when and how much insulin was administered.
2Loss of information
If detailed dose history data is collected and processed to show average and variability, then communication of treatment regimen effectiveness is improved, but data processing complexity increases
Solution Approach 1:
The patent transforms raw dose history data into summarized statistical parameters for each time window: average dose amount and coefficient of variation (CV). This parameter transformation reduces the complexity of processing and visualizing data while preserving critical information about treatment effectiveness. The CV parameter specifically captures variability in a standardized way, enabling comparison across different time periods and providing insight into treatment consistency without requiring complex visualizations of every individual dose event.
3Loss of information
If multi-shape data structures are created to represent average and variability, then visualization effectiveness is improved, but computational requirements increase
Solution Approach 1:
The patent applies partial action by creating multi-shape data structures only for time windows that contain multiple dose events (i.e., where variability analysis is meaningful). Time windows with single or no doses are excluded from detailed analysis. This selective approach reduces computational overhead while maintaining visualization effectiveness for the periods where dose distribution patterns are relevant to treatment evaluation.
Data Source
AI summary
Systems and methods for communicating a dose history configured for representing an average and a variability of a distribution of injections with a blood glucose regulating medicament applied by a subject with a treatment regimen. Past records are obtained from insulin pens applying the treatment regimen. Each record specifies an amount and type of medicament injected, the type being one of a blood glucose regulating medicament, and a timestamp. Assigning single-shape polygons (231) to each record, wherein single-shape polygons (231) is configured for visualizing a polygon (261) with a two-dimensional shape, in a displayed mode. The single-shape polygons are used to create a set of multi-shape data structures comprising corresponding multi-shape polygons (244), configured for visualizing a polygon (265) with a two-dimensional shape, in the displayed mode (260). The multi-shape polygons are configured to be displayed with an increasing intensity, depending on the number of overlapping single-shape polygons used to define the multi-shape polygon. The method also comprises communicating display data (247), comprising (i) the plurality of sets of medicament records, and (ii) the set of multi-shape data structures (240).


